Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial

作者:Richard S. Finn, Philippe Merle, Alessandro Granito, Yi‐Hsiang Huang, Gyorgy Bodoky, Marc Pracht, Osamu Yokosuka, Olivier Rosmorduc, René Gerolami, Chiara Caparello, Roniel Cabrera, Charissa Chang, Weijing Sun, Marie-Aude LeBerre, Annette Baumhauer, Gerold Meinhardt, Jordi Bruix · 发表于:Journal of Hepatology · 年份:2018 · DOI:10.1016/j.jhep.2018.04.010 · 被引用次数:356 · 研究领域:Hepatocellular Carcinoma Treatment and Prognosis、Cancer Mechanisms and Therapy、Liver Disease Diagnosis and Treatment